Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma

Recurrence and metastasis are the major causes of mortality in head and neck squamous cell carcinoma (HNSCC). It is suggested that cancer stem cells (CSCs) play pivotal roles in recurrence and metastasis. Thus, a greater understanding of the mechanisms of CSC regulation may provide opportunities to develop novel therapies for improving survival by controlling recurrence or metastasis. Here, we report that overexpression of the gene encoding the catalytic subunit of PI3K (PIK3CA), the most frequently amplified oncogene in HNSCC, promotes epithelial‐to‐mesenchymal transition and enriches the CSC population. However, PIK3CA is not required to maintain these traits and inhibition of the phosphatidylinositol 3‐kinase (PI3K) signaling pathway paradoxically promotes CSC population. Molecular analysis revealed that overexpression of PIK3CA activates multiple receptor tyrosine kinases (RTKs), in which ephrin receptors (Ephs), tropomyosin receptor kinases (TRK) and mast/stem cell growth factor receptor (c‐Kit) contribute to maintain CSC population. Accordingly, simultaneous inhibition of these RTKs using a multi‐kinase inhibitor ponatinib has a superior effect at eliminating the CSC population and reduces metastasis of PIK3CA‐overexpressing HNSCC cells. Our result suggests that co‐targeting of Ephs, TRKs and the c‐Kit pathway may be effective at eliminating the PI3K‐independent CSC population, thereby providing potential targets for future development of a novel anti‐CSC therapeutic approach for HNSCC patients, particularly for patients with PIK3CA amplification.

[1]  C. Arteaga,et al.  Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors. , 2019, Cancer discovery.

[2]  Piyush B. Gupta,et al.  Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance. , 2019, Cell stem cell.

[3]  Daniela Matei,et al.  Targeting Cancer Stemness in the Clinic: From Hype to Hope. , 2019, Cell stem cell.

[4]  Ralitsa R. Madsen,et al.  Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner , 2018, Proceedings of the National Academy of Sciences.

[5]  F. Meric-Bernstam,et al.  Targeting the PI3K pathway in cancer: are we making headway? , 2018, Nature Reviews Clinical Oncology.

[6]  Robert A. Weinberg,et al.  EMT in cancer , 2018, Nature Reviews Cancer.

[7]  A. Tsirigos,et al.  TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. , 2017, Cell stem cell.

[8]  H. Clevers,et al.  Cancer stem cells revisited , 2017, Nature Medicine.

[9]  Cun-Yu Wang,et al.  Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma. , 2017, Cell stem cell.

[10]  A. Jimeno,et al.  Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumors , 2017, Molecular carcinogenesis.

[11]  Camille Stephan-Otto Attolini,et al.  Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.

[12]  A. Pearson,et al.  5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma , 2016, Clinical Cancer Research.

[13]  J. Lipton,et al.  Ponatinib in the therapy of chronic myeloid leukemia , 2016, Expert review of hematology.

[14]  C. Blanpain,et al.  Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.

[15]  J. Grandis,et al.  Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population. , 2016, Cancer research.

[16]  J. Grandis,et al.  HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management. , 2016, Annual review of medicine.

[17]  M. Kulesz-Martin,et al.  Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling , 2015, Oncogene.

[18]  J. Kusukawa,et al.  CD44v3+/CD24− cells possess cancer stem cell-like properties in human oral squamous cell carcinoma , 2015, International journal of oncology.

[19]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[20]  C. Van Waes,et al.  The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. , 2015, Oral diseases.

[21]  E. Winer,et al.  PIK3CAH1047R and Her2 initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling , 2015, Oncogene.

[22]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[23]  Michael B. Stadler,et al.  PIK3CAH1047R induces multipotency and multi-lineage mammary tumours , 2015, Nature.

[24]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[25]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[26]  Jean J. Zhao,et al.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting , 2014, Nature Reviews Cancer.

[27]  N. Tran,et al.  Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells* , 2014, The Journal of Biological Chemistry.

[28]  H. Lee,et al.  SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma , 2014, British Journal of Cancer.

[29]  D. Carbone,et al.  EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling. , 2014, Cancer research.

[30]  S. Carr,et al.  A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages , 2014, Nature Cell Biology.

[31]  R. Roesler,et al.  Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. , 2014, Neoplasia.

[32]  M. Nieto.  Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells , 2013, Science.

[33]  Simion I. Chiosea,et al.  Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. , 2013, Cancer discovery.

[34]  J. Gutkind,et al.  Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets. , 2013, Cancer discovery.

[35]  R. Gibbs,et al.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. , 2013, Cancer discovery.

[36]  W. Lam,et al.  Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. , 2013, Cancer research.

[37]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[38]  T. Brabletz.  EMT and MET in metastasis: where are the cancer stem cells? , 2012, Cancer cell.

[39]  L. Du,et al.  Role of Phosphatidylinositol-3-Kinase Pathway in Head and Neck Squamous Cell Carcinoma , 2012, Journal of oncology.

[40]  T. Brabletz.  To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.

[41]  Peter Dirks,et al.  Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.

[42]  M. Nieto,et al.  The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.

[43]  Liang Zhou,et al.  BMI1 promotes the progression of laryngeal squamous cell carcinoma. , 2011, Oral oncology.

[44]  T. Carey,et al.  Head and neck cancer stem cells: The side population , 2011, The Laryngoscope.

[45]  M. Hummel,et al.  Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma , 2011, PloS one.

[46]  K. Murai,et al.  Restraining stem cell niche plasticity: a new talent of Eph receptors. , 2010, Cell stem cell.

[47]  H. Brenner,et al.  Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.

[48]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[49]  D. Yu,et al.  TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma , 2010, Oncogene.

[50]  Elena B. Pasquale,et al.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond , 2010, Nature Reviews Cancer.

[51]  T. Clackson,et al.  AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. , 2009, Cancer cell.

[52]  C. Deng,et al.  Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. , 2009, The Journal of clinical investigation.

[53]  Kevin Struhl,et al.  MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells , 2009, Science Signaling.

[54]  T. Carey,et al.  Genotyping of 73 UM‐SCC head and neck squamous cell carcinoma cell lines , 2009, Head & neck.

[55]  Y. Doki,et al.  Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus , 2009, British Journal of Cancer.

[56]  Nicholas J. Wang,et al.  Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.

[57]  Dong M Shin,et al.  Recent advances in head and neck cancer. , 2008, The New England journal of medicine.

[58]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[59]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[60]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[61]  C. Corless,et al.  Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. , 2006, Genes & development.

[62]  Spiros Manolidis,et al.  PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[63]  D. Peeper,et al.  Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB , 2004, Nature.

[64]  M. Miettinen.  Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. , 1991, The American journal of pathology.

[65]  N. Gale,et al.  The role of epithelial-mesenchymal transition in squamous cell carcinoma of the oral cavity , 2018, Virchows Archiv : an international journal of pathology.

[66]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[67]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2016 .

[68]  R. Doebele,et al.  TRKing down an old oncogene in a new era of targeted therapy. , 2015, Cancer discovery.

[69]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[70]  A. Lokshin,et al.  Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. , 2010, Cancer research.

[71]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.